Authors:
HARRIS AW
MISIEWICZ JJ
BARDHAN KD
LEVI S
OMORAIN C
COOPER BT
KERR GD
DIXON MF
LANGWORTHY H
PIPER D
Citation: Aw. Harris et al., INCIDENCE OF DUODENAL-ULCER HEALING AFTER 1 WEEK OF PROTON PUMP INHIBITOR TRIPLE THERAPY FOR ERADICATION OF HELICOBACTER-PYLORI, Alimentary pharmacology & therapeutics, 12(8), 1998, pp. 741-745
Citation: Np. Breslin et al., SCREENING FOR HELICOBACTER-PYLORI IN YOUNG DYSPEPTIC PATIENTS REFERRED FOR INVESTIGATION - ENDOSCOPY FOR THOSE WHO TEST NEGATIVE, Alimentary pharmacology & therapeutics, 12(6), 1998, pp. 577-582
Citation: P. Malfertheiner et al., EFFICACY OF RANITIDINE BISMUTH CITRATE (RBC) DUAL AND TRIPLE THERAPIES FOR THE ERADICATION OF HELICOBACTER-PYLORI - REPLY, Gut, 42(4), 1998, pp. 597-597
Authors:
IRVINE EJ
GRACE E
KERR GD
LYRENAS E
BOLIN T
OMORAIN C
KORMAN M
ZHOU Q
Citation: Ej. Irvine et al., PROBLEMS WHICH ADDRESS HEALTH-RELATED QUALITY-OF-LIFE (HRQOL) IN INFLAMMATORY BOWEL-DISEASE (IBD), Gastroenterology, 114(4), 1998, pp. 4105-4105
Citation: Np. Breslin et al., SURGICAL AND SMOKING HISTORY IN INFLAMMATORY BOWEL-DISEASE - A CASE-CONTROL STUDY, Inflammatory bowel diseases, 3(1), 1997, pp. 1-5
Authors:
FAIVRE J
COUILLAULT C
KRONBORG O
RATH U
GIACOSA A
DEOLIVEIRA H
OBRADOR T
OMORAIN C
ANDREATTA R
BUSET M
CRESPON B
FENGER K
JUSTUM AM
KERR G
LEGOUX JL
MARKS C
MATEK W
OWEN RW
PAILLOT B
PIARD F
PIENKOWSKI P
PIGNATELLE M
PRADA A
PUJOL J
ROZEN P
RICHTER F
SEITZ JF
STURNIOLO GC
ZAMBELLI A
Citation: J. Faivre et al., CHEMOPREVENTION OF METACHRONOUS ADENOMAS OF THE LARGE-BOWEL - DESIGN AND INTERIM RESULTS OF A RANDOMIZED TRIAL OF CALCIUM AND FIBER, European journal of cancer prevention, 6(2), 1997, pp. 132-138
Citation: J. Lee et C. Omorain, CONSENSUS OR CONFUSION - A REVIEW OF EXISTING NATIONAL GUIDELINES ON HELICOBACTER PYLORI-RELATED DISEASE, European journal of gastroenterology & hepatology, 9(5), 1997, pp. 527-531
Citation: N. Breslin et C. Omorain, TONSILLECTOMY AND INFLAMMATORY BOWEL-DISEASE LOCATION, European journal of gastroenterology & hepatology, 9(5), 1997, pp. 543-543
Authors:
MALFERTHEINER P
MEGRAUD F
OMORAIN C
BELL D
PORRO GB
DELTENRE M
FORMAN D
GASBARRINI G
JAUP B
MISIEWICZ JJ
PAJARES J
QUINA M
RAUWS E
Citation: P. Malfertheiner et al., CURRENT EUROPEAN CONCEPTS IN THE MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - THE MAASTRICHT CONSENSUS REPORT, European journal of gastroenterology & hepatology, 9(1), 1997, pp. 1-2
Citation: Np. Breslin et C. Omorain, PEPTIC-ULCER TREATMENT TODAY - IS THERE A ROLE FOR MAINTENANCE THERAPY, The Italian Journal of Gastroenterology, 29(2), 1997, pp. 116-121
Authors:
OKEEFFE P
OMORAIN C
KOMURO S
DEN S
MORIKAWA T
AOYAGI Y
Citation: P. Okeeffe et al., PLASMA INTERACTION PROCESSES DURING THE PULSED-LASER DEPOSITION OF SUPERCONDUCTING THIN-FILMS, Applied surface science, 114, 1997, pp. 202-206
Citation: C. Omorain et M. Whelton, EUROPEAN-UNION OF MEDICAL SPECIALITIES SECTION OF GASTROENTEROLOGY - PRESENT STATUS, Irish journal of medical science, 166(1), 1997, pp. 38-40
Authors:
OCONNOR F
HYDE D
BRESLIN N
LEE J
OMORAIN C
Citation: F. Oconnor et al., HELICOBACTER PYLORI-INDUCED GASTRIC EPITHELIAL-CELL PROLIFERATION IS INDEPENDENT OF THE PRESENCE OF THE CAG-A GENE, Gut, 41, 1997, pp. 168-168
Authors:
CAMPIERI M
FERGUSON A
DOE W
PERSSON T
NILSSON LG
MALCHOW H
PRANTERA C
MANI V
OMORAIN C
SELBY W
PALLONE F
DIPIETRALATA MM
SJODAHL R
FLORIN T
SMITH P
BIANCHI P
LOFBERG R
RUTGEERTS P
SMALLWOOD R
LAMERS HW
TASMANJONES C
HUNTER JO
HODGSON H
DANIELSSON A
LEE FI
PIACITELLI G
GIOVANNI S
ELLIS A
WEIR DG
Citation: M. Campieri et al., ORAL BUDESONIDE IS AS EFFECTIVE AS ORAL PREDNISOLONE IN ACTIVE CROHNS-DISEASE, Gut, 41(2), 1997, pp. 209-214
Authors:
MALFERTHEINER P
MEGRAUD F
OMORAIN C
BELL D
BIANCHI PG
DELTENRE M
FORMAN D
GASBARRINI G
JAUP B
MISIEWICZ G
PAJARES J
QUINA M
RAUWS E
ANDERSEN L
ARENAS MI
BAZZOLI F
BERSTAD A
BIANCHI P
BIRKNER B
BRUN J
BUCKLEY M
BURES J
BUTRUK E
CADRANEL S
CASAS RJ
CASPARY F
COTTRILL M
CULHANE A
DEKOSTER E
DITE P
FARKKILA M
FUJIOKA T
FUKUDA T
GLUPCZYNSKI Y
HIRSCHL A
HUNT R
JOHANNESSEN T
KREJS G
LABENZ J
LAMERS C
LIND T
MCCOLL K
NUESCH H
ODONOGHUE D
OFFER G
PEURA D
POMBAL R
POUNDER R
PRETOLANI P
ROKKAS T
ROMAOZINHO J
RUNE S
SANDELOWSKY H
SEIFERT B
SHIMOYAMA T
SJOLUND K
STOCKBRUGGER R
THOMSON A
UBALDI E
UNGE P
VANCUTSEM E
WADSTROM T
WEBER J
SIPPONEN P
PRICE A
Citation: P. Malfertheiner et al., CURRENT EUROPEAN CONCEPTS IN THE MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - THE MAASTRICHT CONSENSUS REPORT, Gut, 41(1), 1997, pp. 8-13
Authors:
LIND T
MEGRAUD F
BARDHAN KD
BAYERDORFFER E
HELLBLOM M
OMORAIN C
SPILLER RC
UNGE P
VANZANTEN SJOV
WRANGSTADH M
ZEIJLON L
CEDERBERG C
Citation: T. Lind et al., THE MACH2 STUDY - ANTIMICROBIAL RESISTANCE IN HELICOBACTER-PYLORI THERAPY - THE IMPACT OF OMEPRAZOLE, Gut, 41, 1997, pp. 89-89
Authors:
MALFERTHEINER P
BAYERDORFFER E
DIETE U
GIL J
LIND T
MISIUNA P
OMORAIN C
SIPPONEN P
SPILLER RC
STASIEWICZ J
TREICHEL HC
UJSZASZY L
UNGE P
VANZANTEN SJOV
ZEIJLON L
Citation: P. Malfertheiner et al., THE GU-MACH STUDY - ERADICATION OF HELICOBACTER-PYLORI, ULCER HEALINGAND RELAPSE IN GASTRIC-ULCER PATIENTS - OMEPRAZOLE AND CLARITHROMYCININ COMBINATION WITH EITHER AMOXICILLIN OR METRONIDAZOLE, Gut, 41, 1997, pp. 97-97